awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53704361-62CB5042-2A10-4D93-840F-55A93BA74A55
Q53704361-62CB5042-2A10-4D93-840F-55A93BA74A55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53704361-62CB5042-2A10-4D93-840F-55A93BA74A55
Aflibercept in Diabetic Macular Oedema Previously Refractory to Standard Intravitreal Therapy: An Irish Retrospective Study.
P2860
Q53704361-62CB5042-2A10-4D93-840F-55A93BA74A55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53704361-62CB5042-2A10-4D93-840F-55A93BA74A55
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3651605a2af08f8358260654c9d19a8623d31870
P2860
Is it necessary to use three mandatory loading doses when commencing therapy for neovascular age-related macular degeneration using bevacizumab? (BeMOc Trial).